| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetic Neuropathies | 12 | 2022 | 40 | 2.050 |
Why?
|
| Diabetes Mellitus, Experimental | 9 | 2022 | 190 | 1.530 |
Why?
|
| Insulin-Secreting Cells | 8 | 2022 | 397 | 1.110 |
Why?
|
| Hyperglycemia | 3 | 2015 | 176 | 0.810 |
Why?
|
| Vital Statistics | 1 | 2018 | 3 | 0.690 |
Why?
|
| Neural Conduction | 6 | 2020 | 69 | 0.690 |
Why?
|
| Insulin | 10 | 2022 | 1160 | 0.630 |
Why?
|
| Diabetes Mellitus | 4 | 2022 | 806 | 0.620 |
Why?
|
| Gastric Inhibitory Polypeptide | 4 | 2018 | 9 | 0.540 |
Why?
|
| Islets of Langerhans | 4 | 2022 | 544 | 0.520 |
Why?
|
| Insulin Receptor Substrate Proteins | 2 | 2011 | 55 | 0.510 |
Why?
|
| Ganglia, Spinal | 5 | 2021 | 72 | 0.480 |
Why?
|
| Glucagon | 3 | 2022 | 111 | 0.450 |
Why?
|
| Carcinoma, Hepatocellular | 4 | 2015 | 383 | 0.430 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2010 | 376 | 0.420 |
Why?
|
| Feedback, Physiological | 1 | 2011 | 62 | 0.400 |
Why?
|
| Mice, Inbred C57BL | 14 | 2020 | 3092 | 0.400 |
Why?
|
| Liver Neoplasms | 4 | 2015 | 735 | 0.390 |
Why?
|
| Mice | 27 | 2022 | 11352 | 0.390 |
Why?
|
| Hepatocytes | 1 | 2011 | 127 | 0.380 |
Why?
|
| Animals | 38 | 2022 | 26581 | 0.380 |
Why?
|
| Forkhead Transcription Factors | 1 | 2011 | 166 | 0.380 |
Why?
|
| Antibodies, Antinuclear | 1 | 2010 | 83 | 0.360 |
Why?
|
| Quality Control | 1 | 2010 | 117 | 0.360 |
Why?
|
| Liver | 10 | 2017 | 1229 | 0.360 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 316 | 0.350 |
Why?
|
| Weight Gain | 3 | 2018 | 123 | 0.340 |
Why?
|
| Calmodulin | 2 | 2007 | 50 | 0.330 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2020 | 567 | 0.330 |
Why?
|
| Rats | 13 | 2022 | 3990 | 0.310 |
Why?
|
| Proglucagon | 3 | 2022 | 5 | 0.310 |
Why?
|
| Stem Cells | 2 | 2020 | 351 | 0.310 |
Why?
|
| Venoms | 1 | 2007 | 12 | 0.300 |
Why?
|
| Fibroblast Growth Factors | 3 | 2017 | 80 | 0.300 |
Why?
|
| Peptides | 3 | 2022 | 639 | 0.280 |
Why?
|
| Gene Expression Regulation | 2 | 2011 | 1920 | 0.280 |
Why?
|
| Hypoglycemic Agents | 2 | 2019 | 378 | 0.280 |
Why?
|
| Diet, High-Fat | 2 | 2018 | 114 | 0.270 |
Why?
|
| S100 Calcium Binding Protein beta Subunit | 2 | 2017 | 4 | 0.270 |
Why?
|
| Peripheral Nerves | 2 | 2022 | 36 | 0.270 |
Why?
|
| Endoplasmic Reticulum | 1 | 2007 | 250 | 0.270 |
Why?
|
| Nerve Growth Factors | 1 | 2005 | 63 | 0.260 |
Why?
|
| Neuropeptides | 1 | 2005 | 112 | 0.250 |
Why?
|
| Neurotransmitter Agents | 1 | 2005 | 106 | 0.250 |
Why?
|
| Neurons | 4 | 2021 | 1546 | 0.250 |
Why?
|
| Electroretinography | 2 | 2020 | 76 | 0.240 |
Why?
|
| Insulin Resistance | 5 | 2019 | 377 | 0.230 |
Why?
|
| Diabetic Retinopathy | 2 | 2020 | 87 | 0.220 |
Why?
|
| Histological Techniques | 1 | 2022 | 35 | 0.220 |
Why?
|
| Culture Media, Conditioned | 2 | 2020 | 104 | 0.220 |
Why?
|
| Diet, High-Protein | 1 | 2022 | 1 | 0.220 |
Why?
|
| Apoptosis | 5 | 2021 | 1683 | 0.210 |
Why?
|
| Cell Line | 7 | 2021 | 2468 | 0.210 |
Why?
|
| Glucagon-Secreting Cells | 1 | 2022 | 25 | 0.210 |
Why?
|
| Docosahexaenoic Acids | 1 | 2022 | 31 | 0.210 |
Why?
|
| Dietary Carbohydrates | 2 | 2018 | 38 | 0.210 |
Why?
|
| Nerve Fibers | 2 | 2019 | 46 | 0.200 |
Why?
|
| Japan | 2 | 2019 | 307 | 0.200 |
Why?
|
| Promoter Regions, Genetic | 3 | 2015 | 937 | 0.200 |
Why?
|
| Peripheral Nervous System | 1 | 2021 | 21 | 0.200 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 2 | 2019 | 35 | 0.200 |
Why?
|
| Pyruvaldehyde | 1 | 2021 | 10 | 0.200 |
Why?
|
| Tooth, Deciduous | 1 | 2020 | 3 | 0.200 |
Why?
|
| Glucagon-Like Peptides | 1 | 2020 | 8 | 0.190 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2020 | 30 | 0.190 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2020 | 63 | 0.190 |
Why?
|
| Point-of-Care Testing | 1 | 2020 | 24 | 0.190 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 2 | 2018 | 119 | 0.180 |
Why?
|
| Thermosensing | 1 | 2019 | 3 | 0.180 |
Why?
|
| Arginase | 4 | 2001 | 16 | 0.180 |
Why?
|
| Tomography, Optical Coherence | 1 | 2020 | 130 | 0.180 |
Why?
|
| Oxidative Stress | 2 | 2022 | 447 | 0.180 |
Why?
|
| Spiro Compounds | 1 | 2019 | 25 | 0.180 |
Why?
|
| Dental Pulp | 1 | 2019 | 4 | 0.180 |
Why?
|
| Calcium Channels, L-Type | 1 | 2019 | 39 | 0.180 |
Why?
|
| Rats, Wistar | 4 | 2019 | 297 | 0.180 |
Why?
|
| Mice, Knockout | 6 | 2020 | 1924 | 0.170 |
Why?
|
| Electrodiagnosis | 1 | 2019 | 7 | 0.170 |
Why?
|
| Pyrazines | 1 | 2019 | 92 | 0.170 |
Why?
|
| Exocytosis | 1 | 2019 | 108 | 0.170 |
Why?
|
| Male | 22 | 2020 | 40956 | 0.170 |
Why?
|
| Retina | 1 | 2020 | 213 | 0.170 |
Why?
|
| Cyclin D2 | 1 | 2018 | 19 | 0.170 |
Why?
|
| Bone Morphogenetic Protein 4 | 2 | 2015 | 15 | 0.160 |
Why?
|
| Cell Nucleus | 3 | 2019 | 579 | 0.160 |
Why?
|
| Glucose | 3 | 2018 | 638 | 0.160 |
Why?
|
| Stem Cell Transplantation | 1 | 2019 | 183 | 0.160 |
Why?
|
| Point-of-Care Systems | 1 | 2019 | 141 | 0.160 |
Why?
|
| Organ Specificity | 3 | 2017 | 258 | 0.160 |
Why?
|
| Diet, Carbohydrate Loading | 1 | 2017 | 2 | 0.160 |
Why?
|
| Atherosclerosis | 1 | 2020 | 243 | 0.160 |
Why?
|
| Dietary Sucrose | 1 | 2017 | 13 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2020 | 1373 | 0.150 |
Why?
|
| Cause of Death | 1 | 2018 | 277 | 0.150 |
Why?
|
| Adenosine Triphosphate | 1 | 2018 | 314 | 0.150 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2017 | 27 | 0.150 |
Why?
|
| Dietary Fats | 1 | 2018 | 135 | 0.150 |
Why?
|
| Adipose Tissue, Brown | 1 | 2017 | 80 | 0.150 |
Why?
|
| Mice, Transgenic | 7 | 2007 | 1540 | 0.150 |
Why?
|
| Energy Metabolism | 3 | 2017 | 271 | 0.150 |
Why?
|
| Myoblasts | 1 | 2017 | 31 | 0.150 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2017 | 45 | 0.150 |
Why?
|
| Enzyme Inhibitors | 1 | 2019 | 639 | 0.140 |
Why?
|
| Glycolysis | 1 | 2017 | 129 | 0.140 |
Why?
|
| Autoantigens | 3 | 2002 | 127 | 0.140 |
Why?
|
| Neuronal Outgrowth | 3 | 2020 | 5 | 0.140 |
Why?
|
| Glucose Tolerance Test | 4 | 2019 | 228 | 0.140 |
Why?
|
| Clostridium | 1 | 2015 | 21 | 0.130 |
Why?
|
| Palmitic Acid | 1 | 2015 | 26 | 0.130 |
Why?
|
| Sodium-Glucose Transporter 1 | 1 | 2014 | 4 | 0.130 |
Why?
|
| Liver Diseases | 4 | 2001 | 238 | 0.130 |
Why?
|
| Tissue Culture Techniques | 2 | 2011 | 79 | 0.130 |
Why?
|
| Drug Hypersensitivity Syndrome | 1 | 2014 | 2 | 0.130 |
Why?
|
| KATP Channels | 1 | 2014 | 19 | 0.120 |
Why?
|
| Diabetic Foot | 1 | 2014 | 13 | 0.120 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 371 | 0.120 |
Why?
|
| Roseolovirus Infections | 1 | 2014 | 7 | 0.120 |
Why?
|
| Herpesvirus 6, Human | 1 | 2014 | 19 | 0.120 |
Why?
|
| Fatty Liver | 1 | 2015 | 124 | 0.120 |
Why?
|
| RNA, Messenger | 4 | 2020 | 1981 | 0.120 |
Why?
|
| Humans | 25 | 2022 | 86601 | 0.120 |
Why?
|
| Adipocytes, White | 1 | 2013 | 2 | 0.120 |
Why?
|
| Red-Cell Aplasia, Pure | 1 | 2013 | 5 | 0.120 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2014 | 53 | 0.120 |
Why?
|
| Cells, Cultured | 6 | 2020 | 2818 | 0.120 |
Why?
|
| Keratinocytes | 1 | 2014 | 143 | 0.110 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 1208 | 0.110 |
Why?
|
| Gastrointestinal Tract | 1 | 2015 | 191 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2017 | 623 | 0.110 |
Why?
|
| Steroids | 1 | 2014 | 177 | 0.110 |
Why?
|
| Blood Glucose | 3 | 2019 | 873 | 0.110 |
Why?
|
| Receptors, Immunologic | 1 | 2013 | 135 | 0.110 |
Why?
|
| Wound Healing | 2 | 2014 | 344 | 0.110 |
Why?
|
| Neural Crest | 1 | 2012 | 25 | 0.110 |
Why?
|
| Cell Communication | 1 | 2013 | 194 | 0.110 |
Why?
|
| Peptide Fragments | 2 | 2012 | 460 | 0.110 |
Why?
|
| Diet | 1 | 2015 | 443 | 0.100 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2011 | 20 | 0.100 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2011 | 23 | 0.100 |
Why?
|
| Calcineurin | 1 | 2011 | 16 | 0.100 |
Why?
|
| NFATC Transcription Factors | 1 | 2011 | 29 | 0.100 |
Why?
|
| Cell Differentiation | 2 | 2015 | 1458 | 0.100 |
Why?
|
| Response Elements | 1 | 2011 | 63 | 0.100 |
Why?
|
| Glucagon-Like Peptide 1 | 2 | 2022 | 48 | 0.100 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2012 | 104 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2013 | 683 | 0.100 |
Why?
|
| Carotid Intima-Media Thickness | 2 | 2020 | 38 | 0.100 |
Why?
|
| Calcium Signaling | 1 | 2011 | 129 | 0.100 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 2501 | 0.100 |
Why?
|
| DNA Methylation | 1 | 2015 | 628 | 0.090 |
Why?
|
| Macrophages | 1 | 2013 | 554 | 0.090 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 1135 | 0.090 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2010 | 39 | 0.090 |
Why?
|
| Protein Transport | 1 | 2011 | 411 | 0.090 |
Why?
|
| Cytodiagnosis | 3 | 1985 | 42 | 0.090 |
Why?
|
| Cell Survival | 3 | 2021 | 969 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2002 | 425 | 0.090 |
Why?
|
| Autoantibodies | 2 | 2001 | 267 | 0.090 |
Why?
|
| Biomarkers | 4 | 2013 | 1718 | 0.080 |
Why?
|
| Signal Transduction | 2 | 2022 | 3241 | 0.080 |
Why?
|
| Creatine Kinase | 2 | 1998 | 52 | 0.080 |
Why?
|
| Middle Aged | 10 | 2020 | 25017 | 0.080 |
Why?
|
| Neurites | 2 | 2021 | 35 | 0.080 |
Why?
|
| Receptors, Glucagon | 2 | 2020 | 11 | 0.080 |
Why?
|
| Transcription Factor CHOP | 1 | 2007 | 15 | 0.080 |
Why?
|
| Molecular Chaperones | 1 | 2007 | 111 | 0.070 |
Why?
|
| United States | 1 | 2018 | 6665 | 0.070 |
Why?
|
| Heat-Shock Proteins | 1 | 2007 | 179 | 0.070 |
Why?
|
| Receptors, Gastrointestinal Hormone | 2 | 2018 | 5 | 0.070 |
Why?
|
| Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 2005 | 2 | 0.070 |
Why?
|
| Streptozocin | 2 | 2016 | 54 | 0.070 |
Why?
|
| Mice, Inbred ICR | 1 | 2005 | 70 | 0.070 |
Why?
|
| Cyclic AMP | 2 | 2019 | 273 | 0.070 |
Why?
|
| Adult | 5 | 2020 | 25640 | 0.070 |
Why?
|
| Stress, Physiological | 1 | 2007 | 226 | 0.070 |
Why?
|
| Nuclear Proteins | 2 | 2017 | 696 | 0.070 |
Why?
|
| Benzoates | 1 | 2005 | 44 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 879 | 0.060 |
Why?
|
| Glucose Intolerance | 2 | 2018 | 96 | 0.060 |
Why?
|
| Valine | 1 | 2005 | 69 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 1801 | 0.060 |
Why?
|
| Tetrazoles | 1 | 2005 | 50 | 0.060 |
Why?
|
| Diabetic Angiopathies | 1 | 2005 | 62 | 0.060 |
Why?
|
| Female | 12 | 2020 | 44507 | 0.060 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2005 | 90 | 0.060 |
Why?
|
| Benzimidazoles | 1 | 2005 | 140 | 0.060 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 2705 | 0.060 |
Why?
|
| Recombinant Proteins | 2 | 2017 | 1014 | 0.060 |
Why?
|
| tert-Butylhydroperoxide | 1 | 2022 | 2 | 0.050 |
Why?
|
| NAD | 1 | 2022 | 65 | 0.050 |
Why?
|
| Clonal Deletion | 1 | 2002 | 23 | 0.050 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2002 | 66 | 0.050 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2022 | 134 | 0.050 |
Why?
|
| Pancreatic Hormones | 1 | 2022 | 15 | 0.050 |
Why?
|
| Schwann Cells | 1 | 2022 | 34 | 0.050 |
Why?
|
| Rats, Inbred F344 | 1 | 2022 | 156 | 0.050 |
Why?
|
| Specimen Handling | 1 | 2022 | 98 | 0.050 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2022 | 64 | 0.050 |
Why?
|
| Muscle, Skeletal | 2 | 2017 | 449 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 2232 | 0.050 |
Why?
|
| Aged | 5 | 2020 | 18402 | 0.050 |
Why?
|
| Retinal Photoreceptor Cell Outer Segment | 1 | 2020 | 3 | 0.050 |
Why?
|
| Retinal Photoreceptor Cell Inner Segment | 1 | 2020 | 4 | 0.050 |
Why?
|
| Thymus Gland | 1 | 2002 | 195 | 0.050 |
Why?
|
| Pulse Wave Analysis | 1 | 2020 | 10 | 0.050 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2020 | 12 | 0.050 |
Why?
|
| Cell Death | 1 | 2022 | 256 | 0.050 |
Why?
|
| Tooth Exfoliation | 1 | 2020 | 2 | 0.050 |
Why?
|
| Fovea Centralis | 1 | 2020 | 21 | 0.050 |
Why?
|
| Ankle Brachial Index | 1 | 2020 | 27 | 0.050 |
Why?
|
| Liver Transplantation | 2 | 2001 | 1267 | 0.050 |
Why?
|
| Gene Expression | 1 | 2005 | 1284 | 0.050 |
Why?
|
| Hyperalgesia | 1 | 2020 | 16 | 0.050 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2020 | 31 | 0.050 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2021 | 107 | 0.050 |
Why?
|
| Retinal Ganglion Cells | 1 | 2020 | 66 | 0.050 |
Why?
|
| Cell Separation | 1 | 2020 | 196 | 0.050 |
Why?
|
| Autophagy | 1 | 2022 | 149 | 0.050 |
Why?
|
| Electromyography | 1 | 2020 | 183 | 0.050 |
Why?
|
| Aldehyde Reductase | 1 | 2019 | 9 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 6501 | 0.050 |
Why?
|
| Carotid Arteries | 1 | 2020 | 127 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2002 | 372 | 0.040 |
Why?
|
| Monitoring, Physiologic | 1 | 2001 | 268 | 0.040 |
Why?
|
| Ribonucleoprotein, U1 Small Nuclear | 1 | 1999 | 2 | 0.040 |
Why?
|
| Sensory Receptor Cells | 1 | 2019 | 35 | 0.040 |
Why?
|
| Epidermis | 1 | 2019 | 100 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 1673 | 0.040 |
Why?
|
| Immune Tolerance | 1 | 2002 | 337 | 0.040 |
Why?
|
| Calcitonin | 1 | 2019 | 38 | 0.040 |
Why?
|
| Phosphocreatine | 1 | 1998 | 14 | 0.040 |
Why?
|
| Cell Movement | 2 | 2020 | 758 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 187 | 0.040 |
Why?
|
| Motor Skills | 1 | 2019 | 71 | 0.040 |
Why?
|
| Substance P | 1 | 2019 | 61 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2002 | 728 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2017 | 1565 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2002 | 425 | 0.040 |
Why?
|
| Neuroprotective Agents | 1 | 2019 | 94 | 0.040 |
Why?
|
| ROC Curve | 1 | 2020 | 752 | 0.040 |
Why?
|
| Patch-Clamp Techniques | 1 | 2019 | 396 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2020 | 695 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2021 | 480 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2019 | 989 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2019 | 177 | 0.040 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2019 | 182 | 0.040 |
Why?
|
| Starch | 1 | 2017 | 8 | 0.040 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2017 | 19 | 0.040 |
Why?
|
| Uncoupling Protein 1 | 1 | 2017 | 35 | 0.040 |
Why?
|
| Adipose Tissue, White | 1 | 2017 | 18 | 0.040 |
Why?
|
| Antioxidants | 1 | 2019 | 223 | 0.040 |
Why?
|
| Graft Survival | 1 | 2001 | 884 | 0.040 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 54 | 0.040 |
Why?
|
| Mitochondria | 1 | 2021 | 535 | 0.040 |
Why?
|
| Hexokinase | 1 | 2017 | 19 | 0.040 |
Why?
|
| Oxyhemoglobins | 1 | 1996 | 31 | 0.040 |
Why?
|
| Enzyme Induction | 1 | 2017 | 88 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 1999 | 246 | 0.040 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2017 | 46 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2020 | 574 | 0.040 |
Why?
|
| Endotoxins | 1 | 1996 | 36 | 0.040 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2017 | 72 | 0.040 |
Why?
|
| Hypertension | 1 | 2005 | 1141 | 0.030 |
Why?
|
| Erythrocytes | 2 | 2001 | 255 | 0.030 |
Why?
|
| Transcription Factor Pit-1 | 1 | 2015 | 6 | 0.030 |
Why?
|
| LIM-Homeodomain Proteins | 1 | 2015 | 21 | 0.030 |
Why?
|
| Ectoderm | 1 | 2015 | 29 | 0.030 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2015 | 11 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 3636 | 0.030 |
Why?
|
| Paired Box Transcription Factors | 1 | 2015 | 50 | 0.030 |
Why?
|
| Hepatectomy | 1 | 1996 | 166 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 3 | 2002 | 1047 | 0.030 |
Why?
|
| Rats, Zucker | 1 | 2015 | 38 | 0.030 |
Why?
|
| Graft Rejection | 1 | 2001 | 1065 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1804 | 0.030 |
Why?
|
| Phlorhizin | 1 | 2014 | 3 | 0.030 |
Why?
|
| Diazoxide | 1 | 2014 | 19 | 0.030 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 1994 | 5 | 0.030 |
Why?
|
| Lung Diseases | 1 | 1996 | 263 | 0.030 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1994 | 57 | 0.030 |
Why?
|
| Growth Substances | 1 | 1994 | 80 | 0.030 |
Why?
|
| Eye Proteins | 1 | 2015 | 128 | 0.030 |
Why?
|
| Foot | 1 | 2014 | 50 | 0.030 |
Why?
|
| T-Box Domain Proteins | 1 | 2015 | 118 | 0.030 |
Why?
|
| Sulfonylurea Compounds | 1 | 2014 | 64 | 0.030 |
Why?
|
| Receptor for Advanced Glycation End Products | 1 | 2013 | 17 | 0.030 |
Why?
|
| Prognosis | 2 | 2019 | 3674 | 0.030 |
Why?
|
| 3T3-L1 Cells | 1 | 2013 | 32 | 0.030 |
Why?
|
| Adipokines | 1 | 2013 | 19 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 2013 | 46 | 0.030 |
Why?
|
| Paracrine Communication | 1 | 2013 | 31 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2013 | 55 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2013 | 154 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2013 | 164 | 0.030 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2012 | 6 | 0.030 |
Why?
|
| Nerve Growth Factor | 1 | 2012 | 17 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2012 | 28 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2019 | 1578 | 0.030 |
Why?
|
| Sciatic Nerve | 1 | 2012 | 33 | 0.030 |
Why?
|
| Incretins | 1 | 2012 | 14 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2013 | 172 | 0.030 |
Why?
|
| Antibodies, Neutralizing | 1 | 2013 | 112 | 0.030 |
Why?
|
| Mass Screening | 2 | 1989 | 617 | 0.030 |
Why?
|
| Diagnostic Errors | 1 | 2013 | 160 | 0.030 |
Why?
|
| Ovalbumin | 2 | 2002 | 109 | 0.030 |
Why?
|
| Child | 2 | 2020 | 6926 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 536 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2012 | 329 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2012 | 273 | 0.020 |
Why?
|
| Calcineurin Inhibitors | 1 | 2011 | 54 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 1219 | 0.020 |
Why?
|
| Immunization, Secondary | 2 | 2002 | 30 | 0.020 |
Why?
|
| Intestines | 1 | 1994 | 411 | 0.020 |
Why?
|
| Skin | 1 | 2014 | 554 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2012 | 679 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 2011 | 203 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2017 | 1196 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 407 | 0.020 |
Why?
|
| Homeostasis | 1 | 2012 | 409 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 1991 | 115 | 0.020 |
Why?
|
| Quality of Life | 1 | 1996 | 1583 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1753 | 0.020 |
Why?
|
| Cell Division | 2 | 2002 | 696 | 0.020 |
Why?
|
| Obesity | 1 | 2013 | 963 | 0.020 |
Why?
|
| Reference Values | 2 | 2001 | 674 | 0.020 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 1989 | 275 | 0.020 |
Why?
|
| Pattern Recognition, Automated | 2 | 1985 | 217 | 0.020 |
Why?
|
| Oxygen Consumption | 2 | 1996 | 239 | 0.020 |
Why?
|
| Valsartan | 1 | 2005 | 20 | 0.020 |
Why?
|
| Biphenyl Compounds | 1 | 2005 | 68 | 0.020 |
Why?
|
| Probability | 1 | 1985 | 355 | 0.010 |
Why?
|
| Colonic Neoplasms | 2 | 2001 | 556 | 0.010 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2005 | 231 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1989 | 1204 | 0.010 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 2002 | 20 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1989 | 1075 | 0.010 |
Why?
|
| Clonal Anergy | 1 | 2002 | 30 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 2002 | 117 | 0.010 |
Why?
|
| Convalescence | 1 | 2001 | 12 | 0.010 |
Why?
|
| Hepatitis | 1 | 2001 | 35 | 0.010 |
Why?
|
| Carbon Tetrachloride Poisoning | 1 | 2001 | 3 | 0.010 |
Why?
|
| Calibration | 1 | 2001 | 99 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 7988 | 0.010 |
Why?
|
| Cholangiocarcinoma | 1 | 2001 | 66 | 0.010 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2001 | 69 | 0.010 |
Why?
|
| Antigen Presentation | 1 | 2002 | 209 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2002 | 272 | 0.010 |
Why?
|
| Reperfusion Injury | 1 | 2001 | 131 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2001 | 782 | 0.010 |
Why?
|
| Acute Disease | 1 | 2001 | 826 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2005 | 1143 | 0.010 |
Why?
|
| Self Tolerance | 1 | 1999 | 24 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2001 | 456 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 1999 | 171 | 0.010 |
Why?
|
| Galactosamine | 1 | 1998 | 8 | 0.010 |
Why?
|
| Neoplasms | 3 | 1985 | 2897 | 0.010 |
Why?
|
| Alanine Transaminase | 1 | 1998 | 73 | 0.010 |
Why?
|
| Aspartate Aminotransferases | 1 | 1998 | 73 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 1999 | 168 | 0.010 |
Why?
|
| Transgenes | 1 | 1999 | 180 | 0.010 |
Why?
|
| Lupus Nephritis | 1 | 1999 | 78 | 0.010 |
Why?
|
| Necrosis | 1 | 1998 | 204 | 0.010 |
Why?
|
| Rabbits | 1 | 1999 | 636 | 0.010 |
Why?
|
| Isoenzymes | 1 | 1998 | 271 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 1998 | 286 | 0.010 |
Why?
|
| Sulfur Dioxide | 1 | 1996 | 1 | 0.010 |
Why?
|
| Mitochondria, Liver | 1 | 1996 | 27 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2001 | 1990 | 0.010 |
Why?
|
| Hepatic Veins | 1 | 1996 | 27 | 0.010 |
Why?
|
| Adenosine Diphosphate | 1 | 1996 | 55 | 0.010 |
Why?
|
| Oxidative Phosphorylation | 1 | 1996 | 49 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 1996 | 63 | 0.010 |
Why?
|
| Adenine Nucleotides | 1 | 1996 | 63 | 0.010 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 1996 | 70 | 0.010 |
Why?
|
| Portal Vein | 1 | 1996 | 120 | 0.010 |
Why?
|
| Monitoring, Intraoperative | 1 | 1996 | 109 | 0.010 |
Why?
|
| Syndrome | 1 | 1996 | 446 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2001 | 1376 | 0.010 |
Why?
|
| Sepsis | 1 | 1998 | 306 | 0.010 |
Why?
|
| Fibroblast Growth Factor 10 | 1 | 1994 | 6 | 0.010 |
Why?
|
| Fibroblast Growth Factor 7 | 1 | 1994 | 10 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1994 | 256 | 0.010 |
Why?
|
| Kinetics | 1 | 1996 | 1513 | 0.010 |
Why?
|
| Gallbladder Neoplasms | 1 | 1993 | 22 | 0.010 |
Why?
|
| Hemolysis | 1 | 1993 | 61 | 0.010 |
Why?
|
| Epithelium | 1 | 1994 | 319 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 1999 | 1195 | 0.010 |
Why?
|
| Cytokines | 1 | 1996 | 776 | 0.010 |
Why?
|
| Adolescent | 2 | 1996 | 8979 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1994 | 1041 | 0.010 |
Why?
|
| Survival Rate | 1 | 1996 | 1860 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 1994 | 301 | 0.010 |
Why?
|
| Computers | 2 | 1982 | 112 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1991 | 332 | 0.010 |
Why?
|
| Chickens | 1 | 1991 | 212 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1991 | 290 | 0.010 |
Why?
|
| Calpain | 1 | 1991 | 111 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1996 | 1313 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 1994 | 669 | 0.010 |
Why?
|
| Brain | 1 | 1998 | 2216 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1996 | 2600 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1996 | 3352 | 0.000 |
Why?
|